47.41

2.91% 1.34

After Hours: 47.41

Celcuity Inc (CELC)

Overview News Price History Option Chain Financials Discussions Forecast

Celcuity Inc stock is traded at $47.41, with a volume of 1.50M. It is up +2.91% in the last 24 hours and down -13.66% over the past month. Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Previous Close:

$46.07

Open:

$46.85

24h Volume:

1.50M

Relative Volume:

1.04

Market Cap:

$2.01B

Revenue:

Net Income/Loss:

$-63.78M

P/E Ratio:

-17.69

EPS:

-2.68

Net Cash Flow:

$-53.91M

1W Performance:

-0.83%

1M Performance:

-13.66%

6M Performance:

+413.65%

1Y Performance:

+212.73%

1-Day Range:

$45.23

$50.05

1-Week Range:

$45.23

$50.11

52-Week Range:

$7.575

$63.06

Celcuity Inc Stock (CELC) Company Profile

Name

Celcuity Inc

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

763-392-0767

Address

16305 36TH AVENUE N, MINNEAPOLIS, MN

Employee

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

CELC's Discussions on Twitter

Compare CELC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CELC Celcuity Inc	47.41	1.95B	0	-63.78M	-53.91M	-2.68
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Celcuity Inc Stock (CELC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-22-25	Initiated	Guggenheim	Buy
Jul-01-25	Resumed	Stifel	Buy
Jul-22-24	Initiated	Leerink Partners	Outperform
Feb-22-24	Initiated	Stifel	Buy
Dec-08-23	Initiated	H.C. Wainwright	Buy
Oct-08-21	Initiated	Canaccord Genuity	Buy
Sep-07-21	Initiated	Jefferies	Buy
Jul-29-21	Initiated	Cowen	Outperform
Jul-27-21	Initiated	Needham	Buy
Jan-28-21	Reiterated	H.C. Wainwright	Buy
Dec-24-20	Reiterated	H.C. Wainwright	Buy
May-11-20	Resumed	Craig Hallum	Buy
Nov-20-18	Initiated	H.C. Wainwright	Buy

View All

Celcuity Inc Stock (CELC) Latest News

10:51 AM

Will Celcuity Inc. stock benefit from AI adoptionJuly 2025 Review & Safe Capital Investment Plans - newser.com

10:51 AM

05:36 AM

Candlestick signals on Celcuity Inc. stock todayJuly 2025 Earnings & Trade Opportunity Analysis Reports - newser.com

05:36 AM

Oct 11, 2025

Celcuity (NASDAQ:CELC) Stock Price Down 5.1%What's Next? - MarketBeat

Oct 11, 2025

Oct 10, 2025

Historical volatility pattern of Celcuity Inc. visualizedJuly 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Celcuity's (CELC) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

Celcuity: Blink And You Missed It (NASDAQ:CELC) - Seeking Alpha

Oct 08, 2025

Celcuity's VIKTORIA-1 Results To Anchor ESMO Presentation; NDA Submission Underway - RTTNews

Oct 08, 2025

Oct 06, 2025

Short interest data insights for Celcuity Inc.Quarterly Investment Review & Weekly Watchlist of Top Performers - newser.com

Oct 06, 2025

What data driven models say about Celcuity Inc.’s futureTrade Exit Report & Safe Capital Growth Tips - newser.com

Oct 06, 2025

Multi asset correlation models including Celcuity Inc.Weekly Loss Report & Weekly Sector Rotation Insights - newser.com

Oct 06, 2025

Celcuity Inc. stock trend forecastStop Loss & Daily Stock Trend Reports - newser.com

Oct 06, 2025

Long term hold vs stop loss in Celcuity Inc.Layoff News & Daily Growth Stock Investment Tips - newser.com

Oct 06, 2025

Oct 05, 2025

Can technical indicators confirm Celcuity Inc.’s reversal2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com

Oct 05, 2025

Oct 04, 2025

Should FDA Real-Time Review of Gedatolisib Prompt a Closer Look From Celcuity (CELC) Investors? - simplywall.st

Oct 04, 2025

Oct 03, 2025

Needham Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛

Oct 03, 2025

Celcuity (NASDAQ:CELC) Given Buy Rating at Needham & Company LLC - MarketBeat

Oct 03, 2025

How to interpret RSI for Celcuity Inc. stock2025 Institutional Moves & Daily Stock Momentum Reports - newser.com

Oct 03, 2025

Celcuity (CELC): Valuing the Stock After FDA Acceptance of Gedatolisib and Major Pipeline Progress - Sahm

Oct 03, 2025

Celcuity Expands Credit Facility to $500 Million - MSN

Oct 03, 2025

Oct 01, 2025

Why Celcuity Inc. stock appeals to dividend seekers2025 Technical Overview & Smart Investment Allocation Insights - newser.com

Oct 01, 2025

Celcuity (NASDAQ:CELC) Shares Down 4.8%Here's Why - MarketBeat

Oct 01, 2025

Sep 30, 2025

3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth - simplywall.st

Sep 30, 2025